Advanced Dual-Action GLP-1 + GIP Therapy for Weight Management and Type 2 Diabetes
TIDLIRA™ is a next-generation injectable treatment, a breakthrough dual receptor agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual action helps regulate blood sugar, control appetite, and promote significant, sustainable weight loss.
It is now globally recognized for its ability to transform metabolic health by addressing both type 2 diabetes and obesity through a single, comprehensive mechanism.
How It Works
It mimics the body’s natural GIP and GLP-1 hormones, which are responsible for regulating glucose and appetite.
When activated together, these pathways:
Stimulate insulin secretion when blood sugar is high
Reduce glucagon release (which prevents sugar spikes)
Slow gastric emptying for longer fullness
Decrease appetite and calorie intake
This dual mechanism supports effective glycemic control and accelerated fat reduction — without the crash diets or extreme routines.
Key Benefits
Supports healthy blood sugar control
Reduces hunger and promotes satiety
Encourages steady, long-term weight loss
Once-weekly self-injection
Clinically proven and pharmaceutical grade
Concentration: 10mg/ml
Injection Type: Subcutaneous (once weekly)
Syringe Type: Built-in dial with preset delivery
Storage: Refrigerate at 2–8°C after using. Store up to 30 days at below 25°C.
Frequency: Inject once weekly — same day and time each week
Do not shake or freeze. Use only if solution is clear.
One pen lasts 2–12 weeks, depending on your individual dose.

Recommended Dosing Schedule
Weeks
Dose (mg)
Volume (ml)
Notes
1-2
2.5mg
0.25ml
Initiation phase
3-4
5.0mg
0.5ml
Begin fat loss effect
5-6
7.5mg
0.75ml
Enhanced insulin control
7–8
10.0mg
1.0ml
Ideal maintenance dose
 
 
 
 

It should be increased gradually to minimize nausea and digestive discomfort.
TIDLIRA™ 10mg/ml delivers cutting-edge dual-action GLP-1 and GIP support for individuals committed to real, lasting results. With its weekly dosing convenience, precision formulation, and proven clinical performance, it’s the modern solution for weight management and type 2 diabetes control.